Related Experiment Videos
CXCR4 expression mediates glioma cell invasiveness
M Ehtesham1, J A Winston, P Kabos
1Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN 37232-2380, USA. moneeb.ehtesham@vanderbilt.edu
Oncogene
|January 13, 2006
Summary
The chemokine receptor CXCR4 is highly overexpressed in invasive glioblastoma cells and drives tumor invasion. Neutralizing CXCR4 significantly reduces glioblastoma cell invasiveness, highlighting CXCR4 as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Glioblastoma multiforme is an aggressive brain tumor with poor patient outcomes.
- Understanding the molecular mechanisms of glioblastoma invasion is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the role of the chemokine receptor CXCR4 in glioblastoma invasion.
- To explore CXCR4 as a potential therapeutic target for invasive glioblastoma.
Main Methods:
- Assessed CXCR4 expression in invasive and non-invasive glioma cells using quantitative methods.
- Neutralized CXCR4 function in vitro to evaluate its impact on cellular invasion.
- Investigated the role of the ligand CXCL12 in mediating glioma cell invasion.
Main Results:
- Invasive glioma cells showed significantly higher CXCR4 expression (25- to 89-fold) at message and protein levels compared to non-invasive cells.
- Neutralization of CXCR4 markedly reduced the in vitro invasive capacity of malignant glial cells.
- Glioma cells secrete CXCL12 and exhibit directed invasion towards a CXCL12 gradient.
Conclusions:
- CXCR4 plays a critical role in the invasive phenotype of glioblastoma.
- Targeting CXCR4 presents a promising therapeutic strategy for treating invasive glioblastoma.